Cholecalciferol and Calcifediol Are Both Useful to Improve Vitamin D Serum Levels (VITD)

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Status: Enrolling

Conditions: Hypovitaminosis D

Treatments: Dietary Supplement: Vitamin D

Study type: Interventional

Funder types: Other

Identifiers

NCT06138249

VITD (Other Identifier)

Details and patient eligibility

About

Patients with hypovitaminosis D are randomized into three arms of treatment:

Group A: Calcifediol 0,266mg each month Group B: Cholecalciferol 25000UI each 15 days Group C: Calcifediol 4 drops per day. Serum levels of vitamin D are dosed after one month of treatment

Full description

Patients with hypovitaminosis D are randomized into three arms of treatment:

Group A: Calcifediol 0,266mg each month Group B: Cholecalciferol 25000UI each 15 days Group C: Calcifediol 4 drops per day. Serum levels of vitamin D are dosed after one month of treatment to support the best dosage of Vitamin D intake.

Enrollment: 90 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hypovitaminosis D (<20ng/mL)

Exclusion criteria

• Osteoporosis (T score <-2.5SD)
• Renal or hepatic diseases

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

90 participants in 3 patient groups

Calcifediol each month

Experimental group

Description:

Calcifediol 0,266 mg each month

Treatment:

Dietary Supplement: Vitamin D

Cholecalciferol 25.000 UI

Experimental group

Description:

Cholecalciferol 25000UI each 15 days

Treatment:

Dietary Supplement: Vitamin D

Calcifediol 4 drops each day

Experimental group

Description:

Calcifediol 4 drops each day

Treatment:

Dietary Supplement: Vitamin D